Plasma Membrane Integrity During Cell-Cell Fusion and in Response to Pore-Forming Drugs Is Promoted by the

Marcel René Schumann1, Ulrike Brandt1, Christian Adis1

  • 1Institut für Genetik, Technische Universität Braunschweig, 38106, Germany.

Genetics
|July 5, 2019
PubMed

Insights

Researchers identified PEF1, a protein crucial for fungal plasma membrane repair. This discovery sheds light on how fungi maintain cell integrity against injuries and antifungal drugs.

Area of Science:

  • Cell Biology
  • Mycology
  • Biochemistry

Background:

  • Plasma membrane damage is a common cellular event.
  • Fungal membranes are targets for antifungal drugs, but repair mechanisms are poorly understood.
  • Understanding fungal membrane repair is vital for developing new antifungal strategies.

Purpose of the Study:

  • To identify molecular mechanisms of plasma membrane repair in fungi.
  • To investigate the role of the penta-EF-hand protein PEF1 in fungal cell integrity.
  • To explore PEF1's function in response to membrane injury and antifungal agents.

Main Methods:

  • Genetic analysis of *Neurospora crassa* with gene deletions and knockouts.
  • Fluorescence and live-cell imaging to track PEF1 localization.
  • Site-directed mutagenesis to identify functional domains of PEF1.
  • Treatment with pore-forming drugs like tomatine.

Main Results:

  • PEF1 is identified as a key protein in fungal plasma membrane repair.
  • PEF1 accumulates at sites of membrane injury in a calcium-dependent manner.
  • PEF1 is essential for maintaining cell integrity during cell-cell fusion and in the presence of pore-forming drugs.
  • Antifungal treatment induces fungal colony compartmentation, involving PEF1.

Conclusions:

  • Fungal plasma membrane repair is an important defense mechanism against membrane-disrupting drugs.
  • PEF1 plays a critical role in fungal membrane integrity and drug resistance.
  • This study expands the understanding of fungal drug resistance beyond traditional mechanisms.

Related Concept Videos

Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.6K
Introduction to Membrane Proteins01:16

Introduction to Membrane Proteins

The cell membrane, or plasma membrane, is an ever-changing landscape. It is described as a fluid mosaic where various macromolecules are embedded in the phospholipid bilayer. Among the macromolecules are proteins. The protein content varies across cell types. For example, mitochondrial inner membranes contain ~76% protein content, while myelin contains ~18% protein content. Individual cells contain many types of membrane proteins—red blood cells contain over 50—and different cell...
80.7K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.7K
Protein Buffers in Blood Plasma and Cells01:20

Protein Buffers in Blood Plasma and Cells

The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
3.7K
SNAREs and Membrane Fusion01:43

SNAREs and Membrane Fusion

Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.5K
Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.7K